推荐产品
描述
cationic
品質等級
化驗
≥99.0% (AT)
≥99.0%
形狀
crystals
品質
LiChropur™
技術
ion pair chromatography: suitable
mp
141-143 °C (lit.)
144-148 °C
&lambda ;
10 % in acetonitrile
紫外吸收
λ: 290 nm Amax: 0.1
λ: 300 nm Amax: 0.05
λ: 320 nm Amax: 0.02
λ: 500 nm Amax: 0.02
適合性
corresponds to standard for filter test
SMILES 字串
[I-].CCCC[N+](CCCC)(CCCC)CCCC
InChI
1S/C16H36N.HI/c1-5-9-13-17(14-10-6-2,15-11-7-3)16-12-8-4;/h5-16H2,1-4H3;1H/q+1;/p-1
InChI 密鑰
DPKBAXPHAYBPRL-UHFFFAOYSA-M
正在寻找类似产品? 访问 产品对比指南
一般說明
Tetrabutylammonium iodide is an ion-pair chromatography (IPC) reagent suitable for anionic separation sorted by carbon chain length.
應用
Tetrabutylammonium iodide may be used as a mobile phase additive in ion-pair high-performance liquid chromatography (IP-HPLC) assay of 4-aminopyridine in serum. Tetrabutylammonium iodide may also be used as a mobile phase additive in the analysis of tetracycline by reversed-phase IPC. The addition of tetrabutylammonium iodide regulates the retention of tetracyclines.
法律資訊
LiChropur is a trademark of Merck KGaA, Darmstadt, Germany
訊號詞
Warning
危險聲明
危險分類
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 2
閃點(°F)
Not applicable
閃點(°C)
Not applicable
個人防護裝備
dust mask type N95 (US), Eyeshields, Gloves
其他客户在看
Ion-pair high-performance liquid chromatographic assay of 4-aminopyridine in serum
Journal of Chromatography. B, Biomedical Sciences and Applications, 230(2), 363-372 (1982)
Reversed-phase ion-pair liquid chromatography of tetracyclines
Journal of Chromatography A, 209(2), 161-173 (1981)
Journal of chromatography. A, 1284, 141-147 (2013-03-05)
In this study, by using tetrabutylammonium bisulfate as ion-pairing reagent, we were able to separate all the main heparin/heparan sulfate disaccharides generated by the action of heparinases along with the main Hep tetrasaccharide possessing a 3-O-sulfate group on the sulfoglucosamine
Organic letters, 14(13), 3384-3387 (2012-06-27)
A metal-free C-H oxidation for the construction of allylic esters has been developed. The use of a commercially available and inexpensive catalyst and oxidant, and readily available starting materials, coupled with the operational simplicity of the reaction, renders the methodology
Journal of inorganic biochemistry, 121, 77-87 (2013-01-29)
The complex cis-[Ru(phpy)(phen)(CH3CN)2](+) (phpy=2-phenylpyridine, phen=1,10-phenanthroline) was investigated as a potential photodynamic therapy (PDT) agent. This complex presents desirable photochemical characteristics including a low energy absorption tail extending into the PDT window (600-850nm) and photoinduced exchange of the CH3CN ligands, generating
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门